Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

117-96-4

Diatrizoic acid

117-96-4
61-50-7

Dimethyltryptamine

61-50-7
117704-25-3

Doramectin

117704-25-3
3564-73-6

Dihydrocarbamazepine-10,11

3564-73-6
59-92-7

Dopa-L

59-92-7
2757-37-1

Didodecyldisulfide

2757-37-1
17086-28-1

Doxycycline hydrate

17086-28-1
91296-86-5

Difloxacin HCl

91296-86-5
04/03/4342

Dacarbazine

04/03/4342
2353-33-5

Decitabine

2353-33-5
1229-29-4

Doxepin HCl

1229-29-4
147-24-0

Diphenylhydramine HCl

147-24-0
112398-08-0

Danofloxacin

112398-08-0
1266741-05-2

Deferasirox Methyl Ester

1266741-05-2
908-54-3

Diminazene aceturate

908-54-3
5490-27-7

Dihydrostreptomycin sesquisulfate hydrate

5490-27-7
15307-78-5

Diclofenac methyl ester

15307-78-5
15307-77-4

Diclofenac ethyl ester

15307-77-4
73049-39-5

Deoxyribonucleic acid sodium salt from calf thymus 18UNITS/MG

73049-39-5
551-92-8

Dimetridazole

551-92-8